Heidi Anne Duerr, MPH

How can you improve excision care for your patients with hidradenitis suppurativa? Ashley Nicole Elsensohn, MD, MPH, FAAD, shared clinical pearls at the AAD Annual Meeting.

April W. Armstrong, MD, MPH, shared treatment insights with attendees at the 36th Annual Pre-AAD Meeting of the Society for Pediatric Dermatology.

Kelly M. Cordoro, MD, shared tips on implementing shared decision making in pediatric dermatology dermatology atat annual conference.

Dermatology Times chatted with Sonya Kenkare, MD, FAAD, for tips on navigating the annual meeting.

Andrew F. Alexis, MD, MPH, shared insights into using JAK inhibitors as part of the treatment revolution in atopic dermatitis at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Atoosa Kourosh, MD, MPH, delves into opportunities for allergists and dermatologists to collaborate, her approach to cases, and patient resources.

Ama Alexis, MD, shared the importance of recognizing diverse presentations of atopic dermatitis at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.

Session at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting explored issues in understanding and testing for physical urticaria.

Marcella R. Aquino details issues in differential diagnosis for rashes that mimic allergic skin conditions at the ACAAI Annual Meeting.

Karen S. Hsu Blatman, MD, shared key insights on biologics at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.

Kamran H. Imam, MD, hopes to unlock insights into the atopic disease burden among Native American populations.

Late-breaking data adds important safety and efficacy data for leukotriene receptor antagonists augmentation in chronic urticaria treatment.

What are some of the challenges and triumphs in using biologics for atopic dermatitis? Abby L. Allen, RN, NP, shares insights at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting.

The second full day of the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting was filled with new data, important insights, and more.

Research at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting discusses the impact of an educational program on improving care.

Poster presented at American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting yields positive results for adults and children 2 years age and up.

Catch up on highlights from the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.

Ruchi Gupta, MD, MPH, shares tips for supporting a successful transition to college for patients with atopic dermatitis.

Program Chair Jay A. Lieberman, MD, provides a glimpse into the clinical pearls and dermatological educational opportunities presented at the ACAAI 2023 Annual Scientific Meeting.

A new study presented at this year’s American College of Allergy, Asthma and Immunology Annual Scientific Meeting highlights the need for mental health support in patients with atopic dermatitis.

New treatments and clinical insights will be shared at this year's American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

What would you suggest or prescribe for these AD symptoms in a 68-year-old man? Test your knowledge and take a look at new data on AD in older patients.

What are the special considerations for treating pediatric atopic dermatitis? Test your knowledge and hear more from an expert.

A patient with atopic dermatitis presents with redness and other unusual symptoms. What's the diagnosis?

A key session at the annual meeting will share practical advice and tools to better support you and your patients.

What can you do when a medication for psoriasis yields a suboptimal response? New data presented at the 2023 AAD Annual Meeting provides valuable insight on next steps for treatment.

Promising phase 2 data for LY3041658 released during the Late-breaking Research session at the 2023 annual meeting.

Expert warns lack of proper diagnosis and complete and thorough treatment of onychomycosis can lead to an endemic issue.

Designed to address the underlying causes of DEB, the investigational topical gene therapy shows great promise to improve quality of life for patients with this rare disorder.